CD8A and neoplasm: In these studies it was found that the stimulation of anti-viral, anti-tumor and alloreactive CD8+ T cell responses as well as anti-bacterial NKT cell immunity is enhanced in the absence of ATG3, ATG5, ATG7 or ATG16L1 (53–56).